These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3376818

  • 1. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H, Yamada H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y.
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [Abstract] [Full Text] [Related]

  • 2. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H.
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [Abstract] [Full Text] [Related]

  • 3. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Nishikawa E, Yamada Y, Satoh T.
    Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
    [Abstract] [Full Text] [Related]

  • 4. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K.
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [Abstract] [Full Text] [Related]

  • 5. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M.
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [Abstract] [Full Text] [Related]

  • 6. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H, Nonomura H, Miyagawa Y, Waki M, Hatano Y, Hiraiwa S, Muramatsu T, Takamura T, Yamada Y, Nishikawa E.
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [Abstract] [Full Text] [Related]

  • 7. [The study on Thomsen-Friedenreich antigen in bladder tumor].
    Oda Y.
    Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
    [Abstract] [Full Text] [Related]

  • 8. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
    Summers JL, Coon JS, Ward RM, Falor WH, Miller AW, Weinstein RS.
    Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
    [Abstract] [Full Text] [Related]

  • 9. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
    Weinstein RS, Miller AW, Coon JS.
    Prog Clin Biol Res; 1984 Feb; 153():249-60. PubMed ID: 6382282
    [No Abstract] [Full Text] [Related]

  • 10. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU.
    Scand J Urol Nephrol Suppl; 1988 Feb; 112():1-55. PubMed ID: 3068792
    [Abstract] [Full Text] [Related]

  • 11. Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient's clinical course.
    Nishiyama T, Matsumoto Y, Watanabe H, Fujiwara M, Sato S.
    J Natl Cancer Inst; 1987 Jun; 78(6):1113-8. PubMed ID: 3295352
    [Abstract] [Full Text] [Related]

  • 12. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y, Kumon H, Matsumura Y, Ohmori H.
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract] [Full Text] [Related]

  • 13. Thomsen-Friedenreich antigen in bladder cancer tissues detected by monoclonal antibody.
    Yokoyama M, Ohoka H, Oda H, Oda T, Utsumi S, Takeuchi M.
    Hinyokika Kiyo; 1988 Feb; 34(2):255-8. PubMed ID: 3376817
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E, Gutiérrez-Hoyos A, Garrido C, Arozena F.
    Arch Esp Urol; 1991 Feb; 44(1):47-52. PubMed ID: 2064423
    [Abstract] [Full Text] [Related]

  • 15. [Prognostic factors for progression of superficial bladder cancer].
    Sato N, Sumiya H, Isaka S, Shimazaki J, Matsuzaki O.
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [Abstract] [Full Text] [Related]

  • 16. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR.
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [Abstract] [Full Text] [Related]

  • 17. Thomsen-Friedenreich antigen in bladder tumors as detected by specific antibody: a possible marker of recurrence.
    Ohoka H, Shinomiya H, Yokoyama M, Ochi K, Takeuchi M, Utsumi S.
    Urol Res; 1985 Feb; 13(2):47-50. PubMed ID: 4012935
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric evaluation of Thomsen-Friedenreich antigen on transitional cell cancer using monoclonal antibody.
    Oda H, Oda T, Ohoka H, Yokoyama M, Takeuchi M.
    Urol Res; 1990 Feb; 18(2):107-11. PubMed ID: 2339479
    [Abstract] [Full Text] [Related]

  • 19. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T, Fukui I, Yokogawa M, Oshima H.
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T, Tanji S, Koike H, Kubo T, Ohhori T.
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.